“The sky is really the limit in terms of what we can develop here and the impact we can have on these kids’ lives,” Dianna E. Willis, the new director of research for the Burke-Blythedale pediatric neuroscience research collaboration, told the Business Journal during a recent interview.
The chemical element selenium, an essential nutrient for humans and other animals, protects the brain after a stroke and may be a basis for future stroke therapies, according to a study from scientists at Burke Neurological Institute and Weill Cornell Medicine.
A team of scientists have discovered that selenium, a micronutrient, can help boost the antioxidant system on the heels of stroke in animals and suggests that a similar treatment could be used to limit brain damage in patients. Stroke is a leading cause of disability and death in the United States, occurring once every 40 seconds.
Blythedale Children’s Hospital and Burke Neurological Institute announce the appointment of Dianna E. Willis, Ph.D., as Director of Research for the Burke-Blythedale Pediatric Neuroscience Research Collaboration.
The Burke Neurological Institute, the University of Rochester Medical Center and Wadsworth Center of the NYS Department of Health (NYSDOH) were recently awarded a $5 million grant from the Empire State Development C